News & Updates

ADHD meds emerge as preferred option for reducing self-harm risk in BPD
ADHD meds emerge as preferred option for reducing self-harm risk in BPD
04 Jul 2023 byJairia Dela Cruz

For individuals with bipolar disorder (BPD), attention-deficit/hyperactive disorder (ADHD) medications help lower the risk of suicidal behaviour, according to data from a comparative effectiveness research study.

ADHD meds emerge as preferred option for reducing self-harm risk in BPD
04 Jul 2023
Mood disorders affect one in ten ICD patients
Mood disorders affect one in ten ICD patients
04 Jul 2023 byKanas Chan

Depression, anxiety, and post-traumatic stress disorder (PTSD) are highly prevalent in patients with an implantable cardioverter defibrillator (ICD), a meta-analysis has revealed.

Mood disorders affect one in ten ICD patients
04 Jul 2023
Individuals with overactive bladder sleep poorly
Individuals with overactive bladder sleep poorly
03 Jul 2023
Once-weekly icodec affords greater blood sugar reduction than once-daily degludec in T2D
Once-weekly icodec affords greater blood sugar reduction than once-daily degludec in T2D
03 Jul 2023

In the treatment of individuals with insulin-naïve type 2 diabetes (T2D), once-weekly icodec yields superior HbA1c reduction compared with once-daily degludec, according to the results of a phase IIIa trial.

Once-weekly icodec affords greater blood sugar reduction than once-daily degludec in T2D
03 Jul 2023
Newly diagnosed glaucoma ups risk of dementia
Newly diagnosed glaucoma ups risk of dementia
03 Jul 2023

The risk of developing dementia, particularly Alzheimer’s disease (AD), is much higher among individuals with newly diagnosed glaucoma, suggests a study. Additionally, this association is much greater among older individuals.

Newly diagnosed glaucoma ups risk of dementia
03 Jul 2023